The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vitamin K Antagonists (VKA) Market Research Report 2025
Synopsis
Vitamin K is a kind of substance with biological activity of leaf green quinone.
The global Vitamin K Antagonists (VKA) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Rising demand from Asia-Pacific region a major driver for the growth of the market.
This report aims to provide a comprehensive presentation of the global market for Vitamin K Antagonists (VKA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vitamin K Antagonists (VKA).
Report Scope
The Vitamin K Antagonists (VKA) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vitamin K Antagonists (VKA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vitamin K Antagonists (VKA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company
Segment by Type
Oral Vitamin K Antagonists
Injection Vitamin K Antagonists
Segment by Application
VTE
ACS/MI
AF
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vitamin K Antagonists (VKA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vitamin K Antagonists (VKA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vitamin K is a kind of substance with biological activity of leaf green quinone.
The global Vitamin K Antagonists (VKA) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Rising demand from Asia-Pacific region a major driver for the growth of the market.
This report aims to provide a comprehensive presentation of the global market for Vitamin K Antagonists (VKA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vitamin K Antagonists (VKA).
Report Scope
The Vitamin K Antagonists (VKA) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vitamin K Antagonists (VKA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vitamin K Antagonists (VKA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company
Segment by Type
Oral Vitamin K Antagonists
Injection Vitamin K Antagonists
Segment by Application
VTE
ACS/MI
AF
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vitamin K Antagonists (VKA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vitamin K Antagonists (VKA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vitamin K Antagonists (VKA) Market Overview
1.1 Product Overview and Scope of Vitamin K Antagonists (VKA)
1.2 Vitamin K Antagonists (VKA) Segment by Type
1.2.1 Global Vitamin K Antagonists (VKA) Market Value Comparison by Type (2024-2030)
1.2.2 Oral Vitamin K Antagonists
1.2.3 Injection Vitamin K Antagonists
1.3 Vitamin K Antagonists (VKA) Segment by Application
1.3.1 Global Vitamin K Antagonists (VKA) Market Value by Application: (2024-2030)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Global Vitamin K Antagonists (VKA) Market Size Estimates and Forecasts
1.4.1 Global Vitamin K Antagonists (VKA) Revenue 2019-2030
1.4.2 Global Vitamin K Antagonists (VKA) Sales 2019-2030
1.4.3 Global Vitamin K Antagonists (VKA) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vitamin K Antagonists (VKA) Market Competition by Manufacturers
2.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vitamin K Antagonists (VKA) Average Price by Manufacturers (2019-2024)
2.4 Global Vitamin K Antagonists (VKA) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vitamin K Antagonists (VKA), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vitamin K Antagonists (VKA), Product Type & Application
2.7 Vitamin K Antagonists (VKA) Market Competitive Situation and Trends
2.7.1 Vitamin K Antagonists (VKA) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vitamin K Antagonists (VKA) Players Market Share by Revenue
2.7.3 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vitamin K Antagonists (VKA) Retrospective Market Scenario by Region
3.1 Global Vitamin K Antagonists (VKA) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vitamin K Antagonists (VKA) Global Vitamin K Antagonists (VKA) Sales by Region: 2019-2030
3.2.1 Global Vitamin K Antagonists (VKA) Sales by Region: 2019-2024
3.2.2 Global Vitamin K Antagonists (VKA) Sales by Region: 2025-2030
3.3 Global Vitamin K Antagonists (VKA) Global Vitamin K Antagonists (VKA) Revenue by Region: 2019-2030
3.3.1 Global Vitamin K Antagonists (VKA) Revenue by Region: 2019-2024
3.3.2 Global Vitamin K Antagonists (VKA) Revenue by Region: 2025-2030
3.4 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.4.1 North America Vitamin K Antagonists (VKA) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vitamin K Antagonists (VKA) Sales by Country (2019-2030)
3.4.3 North America Vitamin K Antagonists (VKA) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.5.1 Europe Vitamin K Antagonists (VKA) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vitamin K Antagonists (VKA) Sales by Country (2019-2030)
3.5.3 Europe Vitamin K Antagonists (VKA) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.6.1 Asia Pacific Vitamin K Antagonists (VKA) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vitamin K Antagonists (VKA) Sales by Country (2019-2030)
3.6.3 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.7.1 Latin America Vitamin K Antagonists (VKA) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vitamin K Antagonists (VKA) Sales by Country (2019-2030)
3.7.3 Latin America Vitamin K Antagonists (VKA) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.8.1 Middle East and Africa Vitamin K Antagonists (VKA) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vitamin K Antagonists (VKA) Sales by Type (2019-2030)
4.1.1 Global Vitamin K Antagonists (VKA) Sales by Type (2019-2024)
4.1.2 Global Vitamin K Antagonists (VKA) Sales by Type (2025-2030)
4.1.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2019-2030)
4.2 Global Vitamin K Antagonists (VKA) Revenue by Type (2019-2030)
4.2.1 Global Vitamin K Antagonists (VKA) Revenue by Type (2019-2024)
4.2.2 Global Vitamin K Antagonists (VKA) Revenue by Type (2025-2030)
4.2.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2019-2030)
4.3 Global Vitamin K Antagonists (VKA) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vitamin K Antagonists (VKA) Sales by Application (2019-2030)
5.1.1 Global Vitamin K Antagonists (VKA) Sales by Application (2019-2024)
5.1.2 Global Vitamin K Antagonists (VKA) Sales by Application (2025-2030)
5.1.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2019-2030)
5.2 Global Vitamin K Antagonists (VKA) Revenue by Application (2019-2030)
5.2.1 Global Vitamin K Antagonists (VKA) Revenue by Application (2019-2024)
5.2.2 Global Vitamin K Antagonists (VKA) Revenue by Application (2025-2030)
5.2.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2019-2030)
5.3 Global Vitamin K Antagonists (VKA) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Vitamin K Antagonists (VKA) Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Vitamin K Antagonists (VKA) Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Genentech (Roche)
6.5.1 Genentech (Roche) Corporation Information
6.5.2 Genentech (Roche) Description and Business Overview
6.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Product Portfolio
6.5.5 Genentech (Roche) Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Lilly
6.6.1 Lilly Corporation Information
6.6.2 Lilly Description and Business Overview
6.6.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lilly Vitamin K Antagonists (VKA) Product Portfolio
6.7.5 Lilly Recent Developments/Updates
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Corporation Information
6.8.2 Daiichi Sankyo Description and Business Overview
6.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments/Updates
6.9 Otsuka
6.9.1 Otsuka Corporation Information
6.9.2 Otsuka Description and Business Overview
6.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Otsuka Vitamin K Antagonists (VKA) Product Portfolio
6.9.5 Otsuka Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AstraZeneca Vitamin K Antagonists (VKA) Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Vitamin K Antagonists (VKA) Description and Business Overview
6.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Vitamin K Antagonists (VKA) Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Aspen
6.12.1 Aspen Corporation Information
6.12.2 Aspen Vitamin K Antagonists (VKA) Description and Business Overview
6.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aspen Vitamin K Antagonists (VKA) Product Portfolio
6.12.5 Aspen Recent Developments/Updates
6.13 The Medicines Company
6.13.1 The Medicines Company Corporation Information
6.13.2 The Medicines Company Vitamin K Antagonists (VKA) Description and Business Overview
6.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 The Medicines Company Vitamin K Antagonists (VKA) Product Portfolio
6.13.5 The Medicines Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vitamin K Antagonists (VKA) Industry Chain Analysis
7.2 Vitamin K Antagonists (VKA) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vitamin K Antagonists (VKA) Production Mode & Process
7.4 Vitamin K Antagonists (VKA) Sales and Marketing
7.4.1 Vitamin K Antagonists (VKA) Sales Channels
7.4.2 Vitamin K Antagonists (VKA) Distributors
7.5 Vitamin K Antagonists (VKA) Customers
8 Vitamin K Antagonists (VKA) Market Dynamics
8.1 Vitamin K Antagonists (VKA) Industry Trends
8.2 Vitamin K Antagonists (VKA) Market Drivers
8.3 Vitamin K Antagonists (VKA) Market Challenges
8.4 Vitamin K Antagonists (VKA) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Vitamin K Antagonists (VKA) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Vitamin K Antagonists (VKA) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Vitamin K Antagonists (VKA) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Vitamin K Antagonists (VKA) Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Vitamin K Antagonists (VKA) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Vitamin K Antagonists (VKA), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vitamin K Antagonists (VKA), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vitamin K Antagonists (VKA), Product Type & Application
Table 12. Global Key Manufacturers of Vitamin K Antagonists (VKA), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin K Antagonists (VKA) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vitamin K Antagonists (VKA) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Vitamin K Antagonists (VKA) Sales by Region (2019-2024) & (K MT)
Table 18. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2019-2024)
Table 19. Global Vitamin K Antagonists (VKA) Sales by Region (2025-2030) & (K MT)
Table 20. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2025-2030)
Table 21. Global Vitamin K Antagonists (VKA) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2019-2024)
Table 23. Global Vitamin K Antagonists (VKA) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2025-2030)
Table 25. North America Vitamin K Antagonists (VKA) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Vitamin K Antagonists (VKA) Sales by Country (2019-2024) & (K MT)
Table 27. North America Vitamin K Antagonists (VKA) Sales by Country (2025-2030) & (K MT)
Table 28. North America Vitamin K Antagonists (VKA) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Vitamin K Antagonists (VKA) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Vitamin K Antagonists (VKA) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Vitamin K Antagonists (VKA) Sales by Country (2019-2024) & (K MT)
Table 32. Europe Vitamin K Antagonists (VKA) Sales by Country (2025-2030) & (K MT)
Table 33. Europe Vitamin K Antagonists (VKA) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Vitamin K Antagonists (VKA) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vitamin K Antagonists (VKA) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Vitamin K Antagonists (VKA) Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Vitamin K Antagonists (VKA) Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Vitamin K Antagonists (VKA) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vitamin K Antagonists (VKA) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Vitamin K Antagonists (VKA) Sales (K MT) by Type (2019-2024)
Table 51. Global Vitamin K Antagonists (VKA) Sales (K MT) by Type (2025-2030)
Table 52. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2019-2024)
Table 53. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2025-2030)
Table 54. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2019-2024)
Table 57. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2025-2030)
Table 58. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2019-2024)
Table 59. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2025-2030)
Table 60. Global Vitamin K Antagonists (VKA) Sales (K MT) by Application (2019-2024)
Table 61. Global Vitamin K Antagonists (VKA) Sales (K MT) by Application (2025-2030)
Table 62. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2019-2024)
Table 63. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2025-2030)
Table 64. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2019-2024)
Table 67. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2025-2030)
Table 68. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Application (2019-2024)
Table 69. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Sanofi Vitamin K Antagonists (VKA) Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Business Overview
Table 77. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product
Table 79. Bristol-Myers Squibb Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Bayer Vitamin K Antagonists (VKA) Product
Table 84. Bayer Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Johnson & Johnson Vitamin K Antagonists (VKA) Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Genentech (Roche) Corporation Information
Table 91. Genentech (Roche) Description and Business Overview
Table 92. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Genentech (Roche) Vitamin K Antagonists (VKA) Product
Table 94. Genentech (Roche) Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Boehringer Ingelheim Vitamin K Antagonists (VKA) Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Lilly Corporation Information
Table 101. Lilly Description and Business Overview
Table 102. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Lilly Vitamin K Antagonists (VKA) Product
Table 104. Lilly Recent Developments/Updates
Table 105. Daiichi Sankyo Corporation Information
Table 106. Daiichi Sankyo Description and Business Overview
Table 107. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Daiichi Sankyo Vitamin K Antagonists (VKA) Product
Table 109. Daiichi Sankyo Recent Developments/Updates
Table 110. Otsuka Corporation Information
Table 111. Otsuka Description and Business Overview
Table 112. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Otsuka Vitamin K Antagonists (VKA) Product
Table 114. Otsuka Recent Developments/Updates
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. AstraZeneca Vitamin K Antagonists (VKA) Product
Table 119. AstraZeneca Recent Developments/Updates
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Pfizer Vitamin K Antagonists (VKA) Product
Table 124. Pfizer Recent Developments/Updates
Table 125. Aspen Corporation Information
Table 126. Aspen Description and Business Overview
Table 127. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Aspen Vitamin K Antagonists (VKA) Product
Table 129. Aspen Recent Developments/Updates
Table 130. The Medicines Company Corporation Information
Table 131. The Medicines Company Description and Business Overview
Table 132. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. The Medicines Company Vitamin K Antagonists (VKA) Product
Table 134. The Medicines Company Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Vitamin K Antagonists (VKA) Distributors List
Table 138. Vitamin K Antagonists (VKA) Customers List
Table 139. Vitamin K Antagonists (VKA) Market Trends
Table 140. Vitamin K Antagonists (VKA) Market Drivers
Table 141. Vitamin K Antagonists (VKA) Market Challenges
Table 142. Vitamin K Antagonists (VKA) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vitamin K Antagonists (VKA)
Figure 2. Global Vitamin K Antagonists (VKA) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Vitamin K Antagonists (VKA) Market Share by Type in 2023 & 2030
Figure 4. Oral Vitamin K Antagonists Product Picture
Figure 5. Injection Vitamin K Antagonists Product Picture
Figure 6. Global Vitamin K Antagonists (VKA) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Vitamin K Antagonists (VKA) Market Share by Application in 2023 & 2030
Figure 8. VTE
Figure 9. ACS/MI
Figure 10. AF
Figure 11. Others
Figure 12. Global Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Vitamin K Antagonists (VKA) Market Size (2019-2030) & (US$ Million)
Figure 14. Global Vitamin K Antagonists (VKA) Sales (2019-2030) & (K MT)
Figure 15. Global Vitamin K Antagonists (VKA) Average Price (USD/MT) & (2019-2030)
Figure 16. Vitamin K Antagonists (VKA) Report Years Considered
Figure 17. Vitamin K Antagonists (VKA) Sales Share by Manufacturers in 2023
Figure 18. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Vitamin K Antagonists (VKA) Players: Market Share by Revenue in 2023
Figure 20. Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Vitamin K Antagonists (VKA) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Vitamin K Antagonists (VKA) Sales Market Share by Country (2019-2030)
Figure 23. North America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country (2019-2030)
Figure 27. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country (2019-2030)
Figure 28. Germany Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Region (2019-2030)
Figure 35. China Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Country (2019-2030)
Figure 46. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Vitamin K Antagonists (VKA) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Vitamin K Antagonists (VKA) by Type (2019-2030)
Figure 56. Global Revenue Market Share of Vitamin K Antagonists (VKA) by Type (2019-2030)
Figure 57. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2019-2030)
Figure 58. Global Sales Market Share of Vitamin K Antagonists (VKA) by Application (2019-2030)
Figure 59. Global Revenue Market Share of Vitamin K Antagonists (VKA) by Application (2019-2030)
Figure 60. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Application (2019-2030)
Figure 61. Vitamin K Antagonists (VKA) Value Chain
Figure 62. Vitamin K Antagonists (VKA) Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
